Please enable javascript in your browser to view this page correctly
You need to upgrade your Flash PlayerShah AA, Wigley FM, Hummers LK. Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol. 2010;37(1):98-104. Telangiectases are a well recognized physical finding of scleroderma. In this article, Shah and colleagues examined whether increasing numbers of telangiectases were associated with pulmonary hypertension. They counted the number of telangiectases from 11 defined body parts of 147 patients with scleroderma. The patients were assigned a score of 0 if there were no tel ...........
Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary Arterial Hypertension: The EARLY Study Paul R. Forfia, MD; Vallerie V. McLaughlin, MD Medscape Pulmonary Medicine. 2008; ©2008 Medscape Posted 07/31/2008 Introduction and The EARLY Trial Introduction Pulmonar ...........
Exercise Testing to Estimate Survival in Pulmonary Hypertension Herman Groepenhoff; Anton Vonk-Noordegraaf; Anco Boonstra; Marieke D. Spreeuswenberg; Pieter E. Postmus; Harm J. Bogaard Med Sci Sports Exerc. 2008;40(10):1725-1732. ©2008 American College of Sports Medicine Posted Abstrac ...........
Recent Data on the Treatment of Pulmonary Arterial Hypertension: An Expert Interview With Dr. Steven Nathan Medscape Pulmonary Medicine. Posted 11/18/2008 Editor's Note: The last decade has witnessed remarkable improvements in the understanding and treatment of p ...........